GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Market Cap

Replek AD (XMAE:REPL) Market Cap : MKD4,168 Mil (As of Apr. 07, 2025)


View and export this data going back to . Start your Free Trial

What is Replek AD Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Replek AD's share price for the quarter that ended in Dec. 2024 was MKD16598. Replek AD's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 0 Mil. Therefore, Replek AD's market cap for the quarter that ended in Dec. 2024 was MKD4,299 Mil.

Replek AD's quarterly market cap increased from Jun. 2024 (MKD3,004 Mil) to Sep. 2024 (MKD3,883 Mil) and increased from Sep. 2024 (MKD3,883 Mil) to Dec. 2024 (MKD4,299 Mil).

Replek AD's annual market cap increased from Dec. 2022 (MKD2,268 Mil) to Dec. 2023 (MKD2,409 Mil) and increased from Dec. 2023 (MKD2,409 Mil) to Dec. 2024 (MKD4,299 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Replek AD's Enterprise Value for Today is MKD4,479 Mil.


Replek AD Market Cap Historical Data

The historical data trend for Replek AD's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Market Cap Chart

Replek AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,693.60 2,637.92 2,267.55 2,408.70 4,298.88

Replek AD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,201.50 2,408.70 3,004.40 3,883.45 4,298.88

Competitive Comparison of Replek AD's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Replek AD's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's Market Cap distribution charts can be found below:

* The bar in red indicates where Replek AD's Market Cap falls into.


;
;

Replek AD Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Replek AD's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=MKD16598*0.259
=MKD

Replek AD's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=MKD16598*0.259
=MKD4,299

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Replek AD  (XMAE:REPL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Replek AD Market Cap Related Terms

Thank you for viewing the detailed overview of Replek AD's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Replek AD Business Description

Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.